beta-(4-Pyridyl)acrolein Oxalate

Catalog No.: 
ACIJDO521
CAS No.: 
383177-50-2
Molecular Formula: 
C10H9NO5
Molecular Weight: 
223.18
beta-(4-Pyridyl)acrolein Oxalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$217.00InquiryInquiry
250mg97%$408.00InquiryInquiry
1g97%$1616.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namebeta-(4-Pyridyl)acrolein Oxalate
IUPAC Name(E)-3-(pyridin-4-yl)acrylaldehyde oxalate
MDL No.MFCD00191489
Molecular FormulaC10H9NO5
Molecular Weight223.18
SMILESO=C/C=C/C1=CC=NC=C1.O=C(O)C(O)=O
InChI KeyNSTHNVMITOXEJZ-TYYBGVCCSA-N
Synonymbeta-(4-Pyridyl)acroleinOxalate | beta-(4-Pyridyl)acrolein Oxalate | oxalic acid;(E)-3-pyridin-4-ylprop-2-enal | SCHEMBL1678014 | T72403 | P1148
CAS No.383177-50-2
PubChem CID21974133

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIJDO521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBOVJ459 route compound structure diagram
    ACBOVJ4592136-75-6In Stock
  2. Plus
  3. ACBXKY017 route compound structure diagram
    ACBXKY017872-85-5In Stock
  4. Then
  5. ACIJDO521 route product structure diagram
    ACIJDO521383177-50-2
Inquiry

2. ACIJDO521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBXKY017 route compound structure diagram
    ACBXKY017872-85-5In Stock
  2. Then
  3. ACIJDO521 route product structure diagram
    ACIJDO521383177-50-2
Inquiry

3. ACIJDO521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIJDO521 route product structure diagram
    ACIJDO521383177-50-2
Inquiry

Comments (0)